Funded Tech Companies
YolTech Therapeutics
YolTech Therapeutics is a biopharmaceutical company, based in Shanghai. Investment was provided by AstraZeneca and private investors.
Company Overview
Company Name
YolTech Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
12F, Building 1, No. 58 Tanzhu Road, Minhang District
Shanghai, Undisclosed
China
Shanghai, Undisclosed
China
Phone
Website
Email Address
Company Background Information
Overview
YolTech Therapeutics is a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines. Our approach combines innovative gene editing technologies with an advanced lipid nanoparticle (LNP) delivery system, creating a versatile platform designed to address a wide range of serious diseases. Central to our mission is the development of internal capabilities, including end-to-end manufacturing, to ensure the highest standards of quality and scalability. Our lead candidate, targeting ATTR, marks a significant milestone as China's first LNP-mediated in vivo gene editing therapy to enter clinical development. With promising early clinical outcomes, YolTech is also advancing therapies for familial hypercholesterolemia (FH) and primary hyperoxaluria type 1 (PH1). As a company dedicated to transforming the treatment landscape, YolTech continues to push the boundaries of what is possible in gene editing.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/11/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yuxuan Wu
Company Investors
- AstraZeneca
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs